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LETTERS
NEURON – a network of
European funding organizations
There is little doubt that the maintenance and restoration of
health are highly valued and fundamental to citizens in all
countries. Among the many diseases affecting health, brain
disorders are major causes for impaired quality of life.
According to estimates by the World Health Organization,
more than one billion people suffer from disorders of the
central nervous system (WHO 2001). In Europe,
approximately one-third of all burden of disease is caused
by brain diseases (Olesen and Leonardi 2003). With
increasing average life-expectancy, especially in highly
industrialized countries, and the rapidly growing incidence
of neurodegenerative diseases, this percentage will rise even
further. Neuroscience research and its translation into
diagnostic and therapeutic measures is therefore a high
priority.
This fact is clearly recognized by health research policy
makers and is reflected in the considerable amount of money
allocated to the support of neurological and psychiatric
research. However, while the cooperation level among
research institutions in the various European countries
appears satisfactory, clear deficiencies are present with
regard to the coordination of respective research funding.
Funding activities are fragmented and scattered at national
and regional levels, and only few approaches have been
made to phase them. Thus, the coordination of national and
regional funding programs can improve the efficient use of
high but still limited resources and increase their impact.
Coordinated funding activities can avoid redundancy, fill
gaps, and use synergies.
The field of neuroscience research in the global context
is highly competitive. Combining the best research groups
through coordinated or even joint-funding activities will
increase the impact of European neuroscience research.
Already existing transnational research collaborations can
be strengthened, the formation of new interdisciplinary
research consortia initiated and promoted, and the translation
of results into health care improved. This will contribute to
the creation of a “European Research Area” (ERA). The
concept to create a Europe of knowledge and an “internal
market” in research was launched at the European Council
meeting, Lisbon, 2000, and has underpinned discussions of
research policy issues in Europe ever since (see COM 2000,
2001; Sautter et al 2003).
Increased networking among European funding bodies
is one way to meet the challenge of competition that Europe
is facing in biomedical and health research, primarily from
the USA and Japan. This idea is the starting point of
NEURON (Network of European Funding on Neurological
Research), a project initiated by funding agencies and
research or health ministries from four countries, and funded
by the European Union (EU) Commission within the ERA-
Net scheme, a new funding instrument of the 6th Framework
Program. Other funding bodies have joined the project so
that currently ten EU member states and associated countries
participate (Table 1). As endpoints of this process the
opening of national programs for applicants from
participating countries and joint calls for proposals are
envisaged.
Some of the specific objectives of the NEURON network
are to:
• Share information about existing national neuroscience
research programs in Europe and their management. To
analyze them and identify the most promising areas for
joint initiatives.
• Achieve an added value for the considerable European
investments into the area of neurological and psychiatric
research by coordinating the existing but highly
fragmented neuroscience research programs in Europe.
• Shape future national research programs and initiate the
development of European priorities by providing a
structured forum for health research policy makers,
Table 1 Ministries and funding agencies participating in the
ERA-Net NEURON
Germany PT-DLR, Projekttraeger im Deutschen Zentrum fuer
Luft- und Raumfahrt, coordinator of NEURON;
Project Management Organization on behalf of the
Federal Ministry of Education and Research (BMBF)
Luxemburg FNR, Fonds National de la Recherche
Poland MSRIT, Ministry of Scientific Research and Information
Technology
Israel CSO-MOH, Chief Scientist Office, Ministry of Health
Austria FWF, The Austrian Science Fund
France Inserm, Institute of Health and Medical Research
Sweden SRC, Swedish Research Council
Finland AKA, Academy of Finland
Italy  Ministry of Health
Great Britain MRC, Medical Research CouncilNeuropsychiatric Disease and Treatment 2005:1(1) 88
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program managers, the scientific community, and patient
organizations.
• Serve as an interface between society and science in
Europe by promoting knowledge transfer from
neuroscience research to patients suffering from brain
disorders, and to increase public awareness for
neuroscience research, health research policy, and
translational research.
In NEURON as well as in other ERA-Nets, funding
organizations exchange information about their work, their
review procedures, and funding philosophies. This already
is an achievement and will eventually lead to improvement
of standards throughout partner countries. The ultimate goal
of the ERA-Net scheme, however, is to initiate joint funding
from national research budgets. Presently, these budgets are
more or less strictly limited to national borders, and funding
across borders is usually not possible. Concepts regarding
how to overcome legal and administrative barriers need to
be developed. Eventually, it will depend on the political will
in each country whether the ambitious aims of NEURON
and other ERA-Nets will materialize. There is no doubt that
this would be beneficial to the scientific community and to
the patients suffering from brain diseases.
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